Yan Li

Title: Yan Li - Innovator in Recombinant Adenoviruses and Stem Cell Technology.

Introduction

Yan Li is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant adenoviruses and their applications in stem cell therapy. His innovative work has the potential to revolutionize cancer treatment.

Latest Patents

Yan Li holds a patent for "Recombinant adenoviruses and stem cells comprising same." This invention relates to recombinant adenoviruses that exhibit an excellent ability to be introduced into stem cells, even at low concentrations. The stem cells that incorporate these adenoviruses demonstrate remarkable in vivo survivability and effective treatment against tumor cells. When utilized as an anticancer drug, these stem cells do not present issues related to in vivo survival or hepatotoxicity, making them particularly suitable for systemic administration. The invention showcases an excellent anticancer effect even in small doses, highlighting its potential as a widely usable anticancer drug.

Career Highlights

Yan Li is associated with Genemedicine Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for cancer patients through innovative biotechnological solutions.

Collaborations

Yan Li collaborates with Chae Ok Yun, who is also involved in the research and development efforts at Genemedicine Co., Ltd. Their partnership enhances the potential for groundbreaking advancements in the field of biotechnology.

Conclusion

Yan Li's contributions to recombinant adenoviruses and stem cell technology represent a significant advancement in cancer treatment. His innovative approach and dedication to research continue to inspire progress in the field.